Eran Broshy - Net Worth and Insider Trading
Eran Broshy Net Worth
The estimated net worth of Eran Broshy is at least $917,096 dollars as of 2024-12-02. Eran Broshy is the Director of Magellan Health Inc and owns about 7,960 shares of Magellan Health Inc (MGLN) stock worth over $756,120. Eran Broshy is also the Director of Certara Inc and owns about 14,360 shares of Certara Inc (CERT) stock worth over $160,976. Details can be seen in Eran Broshy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eran Broshy has not made any transactions after 2023-08-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eran Broshy
Eran Broshy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eran Broshy owns 3 companies in total, including Theravance Biopharma Inc (TBPH) , Magellan Health Inc (MGLN) , and Certara Inc (CERT) .
Click here to see the complete history of Eran Broshy’s form 4 insider trades.
Insider Ownership Summary of Eran Broshy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2014-06-03 | director |
| MGLN | Magellan Health Inc | 2018-05-24 | director |
| CERT | Certara Inc | 2023-08-22 | director |
Eran Broshy Latest Holdings Summary
Eran Broshy currently owns a total of 2 stocks. Among these stocks, Eran Broshy owns 7,960 shares of Magellan Health Inc (MGLN) as of February 23, 2017, with a value of $756,120 and a weighting of 82.45%. Eran Broshy also owns 14,360 shares of Certara Inc (CERT) as of August 22, 2023, with a value of $160,976 and a weighting of 17.55%.
Latest Holdings of Eran Broshy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MGLN | Magellan Health Inc | 2017-02-23 | 7,960 | 94.99 | 756,120 |
| CERT | Certara Inc | 2023-08-22 | 14,360 | 11.21 | 160,976 |
Holding Weightings of Eran Broshy
Eran Broshy Form 4 Trading Tracker
According to the SEC Form 4 filings, Eran Broshy has made a total of 0 transactions in Magellan Health Inc (MGLN) over the past 5 years. The most-recent trade in Magellan Health Inc is the sale of 4,867 shares on February 23, 2017, which brought Eran Broshy around $389,360.
According to the SEC Form 4 filings, Eran Broshy has made a total of 1 transactions in Certara Inc (CERT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Certara Inc is the acquisition of 5,000 shares on August 22, 2023, which cost Eran Broshy around $79,050.
Insider Trading History of Eran Broshy
- 1
Eran Broshy Trading Performance
GuruFocus tracks the stock performance after each of Eran Broshy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eran Broshy is -4.53%. GuruFocus also compares Eran Broshy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eran Broshy within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eran Broshy's insider trading performs compared to the benchmark.
Performance of Eran Broshy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.15 | | | | | |
| Relative Return to S&P 500(%) | -8.61 | | | | | |
Eran Broshy Ownership Network
Eran Broshy Owned Company Details
What does Theravance Biopharma Inc do?
Who are the key executives at Theravance Biopharma Inc?
Eran Broshy is the director of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include SVP & Comm & Medical Affairs Rhonda Farnum , 10 percent owner Eli Samaha , and SVP & Development Richard A Graham .
Theravance Biopharma Inc (TBPH) Insider Trades Summary
Over the past 18 months, Eran Broshy made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 14,412 shares made by Richard A Graham , a net sale of 14,229 shares made by Rhonda Farnum , and a net purchase of 2,498,924 shares made by Eli Samaha .
In summary, during the past 3 months, insiders sold 4,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net sale of 4,000 shares. During the past 18 months, 28,641 shares of Theravance Biopharma Inc (TBPH) were sold and 2,498,924 shares were bought by its insiders, resulting in a net purchase of 2,470,283 shares.
Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Theravance Biopharma Inc Insider Transactions
Eran Broshy Mailing Address
Above is the net worth, insider trading, and ownership report for Eran Broshy. You might contact Eran Broshy via mailing address: C/o Ventiv Health, 200 Cottontail Ln. Vantage Court N., Somerset Nj 08873.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
